Biochemical basis for the enhanced toxicity of deoxyribonucleosides toward malignant human T cell lines.
D A Carson, Jonathan Kaye, Steven S. Matsumoto, J. Edwin Seegmiller, L. Thompson
Abstract
Open-access reader
D A Carson, Jonathan Kaye, Steven S. Matsumoto, J. Edwin Seegmiller, L. Thompson
Abstract
Open-access reader
Human malignant T cell lines have high levels of deoxyribonucleoside phosphorylating activity and low levels of deoxyribonucleotide dephosphorylating activity. When incubated with deoxyadenosine or thymidine, the malignant T cell lines rapidly accumulate toxic concentrations of dATP and dTTP, respectively. This unusual pattern of deoxyribonucleotide metabolism renders the malignant T cells especially vulnerable to the toxic effects of deoxyribonucleosides and related analogues.
OpenAlex reports 179 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Human malignant T cell lines have high levels of deoxyribonucleoside phosphorylating activity and low levels of deoxyribonucleotide dephosphorylating activity. When incubated with deoxyadenosine or thymidine, the malignant T cell lines rapidly accumulate toxic concentrations of dATP and dTTP, respectively. This unusual pattern of deoxyribonucleotide metabolism renders the malignant T cells especially vulnerable to the toxic effects of deoxyribonucleosides and related analogues.
Key concepts: Deoxyribonucleosides, Deoxyribonucleoside, Deoxyribonucleotide, Deoxyadenosine, Biochemistry, Cell culture, Thymidine, Chemistry